Carl C. Awh - Concepedia

Author

Carl C. Awh

Tennessee Retina

Also Known As

C. C. Awh, CARL C AWH, CARL C. AWH, Carl Awh, Carl C Awh, Carl C. Awh, Everton Arrindell, Virgil Alfaro

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Tennessee Retina Duke University Ophthalmic Consultants of Boston Cleveland Clinic University of Pennsylvania

About

Carl C. Awh is an author at Tennessee Retina specializing in medicine, ophthalmology, and age-related diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2.4K
2	Health Sciences	1	1	27
3	Public Health	1	1	61
4	Allergy	1	1	22
5	Diabetes	1	1	105

Carl C. Awh

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study Peter A. Campochiaro, David M. Brown, Carl C. Awh, Ophthalmology Macular EdemaOcular DiseaseVitreous BodyOphthalmologySurgery	2011	698
Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration David S. Boyer, Andrew N. Antoszyk, Carl C. Awh, Ophthalmology Ocular DiseaseOphthalmologyExperimental OphthalmologyAge-related DiseasesMarina Study	2007	395
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz, The Lancet Ocular DiseaseOphthalmologyAge-related DiseasesGeographic AtrophyAge-related Macular Degeneration	2023	372
HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Michael Singer, Carl C. Awh, Srinivas R. Sadda, Ophthalmology Ocular DiseaseOpen-label Extension TrialOphthalmologyAge-related DiseasesChoroidal Neovascularization Secondary	2012	355
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh, Ophthalmology	2019	262
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion Ingrid U. Scott, Paul VanVeldhuisen, Michael S. Ip, JAMA	2017	211
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials Alex Willoughby, Gui‐Shuang Ying, Cynthia A. Toth, Ophthalmology Ocular DiseaseRetinaVitreous BodyOphthalmologyAge-related Diseases	2015	204
TENAYA and LUCERNE Arshad M. Khanani, Aachal Kotecha, Andrew Chang, Ophthalmology	2024	124
CFH and ARMS2 Genetic Polymorphisms Predict Response to Antioxidants and Zinc in Patients with Age-related Macular Degeneration Carl C. Awh, Anne-Marie Lane, Steven Hawken, Ophthalmology Ocular DiseaseAgingOphthalmologyGeneticsAge-related Diseases	2013	121
Faricimab Treat-and-Extend for Diabetic Macular Edema Tien Yin Wong, Zdenka Hašková, Kemal Asik, Ophthalmology Faricimab Treat-and-extendDiabetic RetinopathyOcular DiseaseOphthalmologyDiabetes	2023	105

Page 1